Vincerx Pharma Company Insiders
VINC Stock | USD 0.26 0.01 4.00% |
Vincerx Pharma's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Vincerx Pharma suggests that all insiders are extremely bullish. Vincerx Pharma employs about 42 people. The company is managed by 15 executives with a total tenure of roughly 98 years, averaging almost 6.0 years of service per executive, having 2.8 employees per reported executive.
Vincerx Pharma's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
2023-08-11 | Alexander A Seelenberger | Acquired 10500 @ 0.95 | View | ||
2023-08-09 | Ahmed Md Hamdy | Acquired 16900 @ 0.95 | View | ||
2022-12-14 | Raquel E Izumi | Acquired 28738 @ 0.88 | View | ||
2022-08-24 | Christopher P Lowe | Acquired 18400 @ 1.65 | View | ||
2022-06-27 | Raquel E Izumi | Acquired 40000 @ 1.41 | View | ||
2022-06-23 | Ahmed Md Hamdy | Acquired 24200 @ 1.41 | View | ||
2022-06-09 | Laura I Bushnell | Acquired 15000 @ 1.91 | View | ||
2021-12-22 | Laura I Bushnell | Acquired 2402 @ 10.48 | View |
Monitoring Vincerx Pharma's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Vincerx |
Vincerx Pharma Management Team Effectiveness
The company has return on total asset (ROA) of (0.6599) % which means that it has lost $0.6599 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4245) %, meaning that it created substantial loss on money invested by shareholders. Vincerx Pharma's management efficiency ratios could be used to measure how well Vincerx Pharma manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -2.09. The current year's Return On Capital Employed is expected to grow to -3.21. At present, Vincerx Pharma's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 17.3 M.As of November 28, 2024, Common Stock Shares Outstanding is expected to decline to about 17.3 M. The current year's Net Loss is expected to grow to about (55.9 M)
Vincerx Pharma Workforce Comparison
Vincerx Pharma is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,411. Vincerx Pharma holds roughly 42.0 in number of employees claiming about 2.98% of equities under Health Care industry.
Vincerx Pharma Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vincerx Pharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vincerx Pharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Vincerx Pharma insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Vincerx Pharma Notable Stakeholders
A Vincerx Pharma stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vincerx Pharma often face trade-offs trying to please all of them. Vincerx Pharma's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vincerx Pharma's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Tom JD | General Founder | Profile | |
Ahmed MD | Chairman CoFounder | Profile | |
Raquel Izumi | President, CoFounder | Profile | |
Raj MBA | VP Manufacturing | Profile | |
Melissa SPHR | Director Culture | Profile | |
Karen Quarford | Vice Compliance | Profile | |
Karen MBA | Vice Compliance | Profile | |
John MD | Founder Board | Profile | |
Beatrix StelteLudwig | Executive Officer | Profile | |
HansGeorg Lerchen | Chief Officer | Profile | |
Steven RPh | Chief Officer | Profile | |
MBA MBA | Chief Officer | Profile | |
David MBA | Head Devel | Profile | |
Alexander MBA | Chief Officer | Profile | |
Gabriela Jairala | Sr Communications | Profile |
About Vincerx Pharma Management Performance
The success or failure of an entity such as Vincerx Pharma often depends on how effective the management is. Vincerx Pharma management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vincerx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vincerx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.20) | (2.09) | |
Return On Capital Employed | (3.38) | (3.21) | |
Return On Assets | (2.20) | (2.09) | |
Return On Equity | (3.58) | (3.40) |
Please note, the presentation of Vincerx Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vincerx Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Vincerx Pharma's management manipulating its earnings.
Vincerx Pharma Workforce Analysis
Traditionally, organizations such as Vincerx Pharma use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vincerx Pharma within its industry.Vincerx Pharma Manpower Efficiency
Return on Vincerx Pharma Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 956.1K | |
Net Loss Per Executive | 2.7M | |
Working Capital Per Employee | 217.3K | |
Working Capital Per Executive | 608.5K |
Complementary Tools for Vincerx Stock analysis
When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |